Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
This dynamic can trouble even the most skilled investors, but luckily for you, we started StockStory to help you navigate these trade-offs and uncover exceptional companies that break the mold. That said, here is one large-cap stock with attractive long-term potential and two whose existing offerings may be tapped out.
Market Cap: $53.79 billion
With a higher focus on style and aesthetics compared to other large general merchandise retailers, Target (NYSE:TGT) serves the suburban consumer who is looking for a wide range of products under one roof.
Why Do We Pass on TGT?
-
Weak same-store sales trends over the past two years suggest there may be few opportunities in its core markets to open new locations
-
Widely-available products (and therefore stiff competition) result in an inferior gross margin of 28.1% that must be offset through higher volumes
-
Subpar operating margin of 5.1% constrains its ability to invest in process improvements or effectively respond to new competitive threats
At $118.40 per share, Target trades at 14.9x forward P/E. Dive into our free research report to see why there are better opportunities than TGT.
Market Cap: $77.69 billion
Widely known for its success in the paint industry, Sherwin-Williams (NYSE:SHW) is a manufacturer of paints, coatings, and related products.
Why Are We Cautious About SHW?
-
Scale is a double-edged sword because it limits the company’s growth potential compared to its smaller competitors, as reflected in its below-average annual revenue increases of 1.1% for the last two years
-
Demand will likely be soft over the next 12 months as Wall Street’s estimates imply tepid growth of 4.2%
-
Earnings per share lagged its peers over the last two years as they only grew by 5.2% annually
Sherwin-Williams’s stock price of $315.90 implies a valuation ratio of 26.5x forward P/E. To fully understand why you should be careful with SHW, check out our full research report (it’s free).
Market Cap: $60.29 billion
Formerly known as AmerisourceBergen until its 2023 rebranding, Cencora (NYSE:COR) is a global pharmaceutical distribution company that connects manufacturers with healthcare providers while offering logistics, data analytics, and consulting services.
Why Will COR Outperform?
-
Dominant market position is represented by its $325.8 billion in revenue, which gives it negotiating power over membership pricing and reimbursement rates
-
Share repurchases over the last five years enabled its annual earnings per share growth of 14.5% to outpace its revenue gains
-
Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures
